AMS is pleased to announce the installation of the BSL-177 system, a device designed to remove Lutetium-177 (Lu-177), at the National Cancer Center Hospital (Tokyo, Japan) as part of a collaborative research project with the institution.

The study, titled "Evaluation of Performance and Efficacy of the Lu-177 Removal System (BSL177)" (Research ID: 2024-353), is led by Dr. Kimiteru Ito of the National Cancer Center Hospital. The research aims to assess the BSL-177 system’s ability to safely and effectively manage radioactive waste generated during Lu-177–based radiopharmaceutical therapy.

On May 14, 2025, the first Lu-177 adsorption experiment using the BSL-177 system was successfully conducted, marking a significant milestone in the collaboration.

This initiative reinforces AMS’s commitment to advancing the safety and environmental management of radiopharmaceutical treatments, while supporting clinical partners and pharmaceutical innovators in meeting growing technical and regulatory demands.